EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Network Medicine: A Potential Approach for Virtual Drug Screening

Mingxuan Ma, Mei Huang, Yinting He, Jiansong Fang iD, Jiachao Li, Xiaohan Li, Mengchen Liu, Mei Zhou, Guozhen Cui iD, Qing Fan

Pharmaceuticals · 06.07.2024 · 17 (7) · 899

DOI: 10.3390/ph17070899 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 06.07.2024. Verfasst von Mingxuan Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai 519000, China. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guizhou Province Science and Technology Program, PhD Start-up Fund of Zunyi Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traditional drug screening methods typically focus on a single protein target and exhibit limited efficiency due to the multifactorial nature of most diseases, which result from disturbances within complex networks of protein–protein interactions rather than single gene abnormalities. Addressing this limitation requires a comprehensive drug screening strategy. Network medicine is rooted in systems biology and provides a comprehensive framework for understanding disease mechanisms, prevention, and therapeutic innovations. This approach not only explores the associations between various diseases but also quantifies the relationships between disease genes and drug targets within interactome networks, thus facilitating the prediction of drug–disease relationships and enabling the screening of therapeutic drugs for specific complex diseases. An increasing body of research supports the efficiency and utility of network-based strategies in drug screening. This review highlights the transformative potential of network medicine in virtual therapeutic screening for complex diseases, offering novel insights and a robust foundation for future drug discovery endeavors.

Schlagwörter

Stichwörter der Autor:innen

disease genedrug screeningdrug targetnetwork medicinenetwork proximityomicsprotein–protein interaction (PPI)

Autor:innen und Institutionen

  • School of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai 519000, China.
  • Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 570000, China.
  • Basic Medical Science Department, Zhuhai Campus of Zunyi Medical University, Zhuhai 519041, China.

ORCID-Profile: Jiansong Fang, Guozhen Cui

Förderung

  • National Natural Science Foundation of China
  • Guizhou Province Science and Technology Program
  • PhD Start-up Fund of Zunyi Medical University

Zitieren

APA

Ma, M., Huang, M., He, Y., Fang, J., Li, J., Li, X., Liu, M., Zhou, M., Cui, G., & Fan, Q. (2024). Network Medicine: A Potential Approach for Virtual Drug Screening. Pharmaceuticals, 17(7), 899. https://doi.org/10.3390/ph17070899

Vancouver

Ma M, Huang M, He Y, Fang J, Li J, Li X, et al. Network Medicine: A Potential Approach for Virtual Drug Screening. Pharmaceuticals. 2024;17(7):899. doi:10.3390/ph17070899

BibTeX
@article{Ma2024,
  author = {Ma, Mingxuan and Huang, Mei and He, Yinting and Fang, Jiansong and Li, Jiachao and Li, Xiaohan and Liu, Mengchen and Zhou, Mei and Cui, Guozhen and Fan, Qing},
  title = {Network Medicine: A Potential Approach for Virtual Drug Screening},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {7},
  pages = {899},
  doi = {10.3390/ph17070899}
}
Kostenlos starten →